E-DRUG: Independent Drug and Healthcare Newsletter for December 2018
----------------------------------------------------------------------------------------
Newsletter, December 2018
Independent Drug & Healthcare Newsletter from the non-profit journal Prescrire International
View the contents
If your friends or colleagues would be interested, forward this email and invite them to sign up for the free Newsletter.
Like what you see?
Subscribe to Prescrire International
In Prescrire's Spotlight this month
--------------------------------------------------------------------------------
FEATURED REVIEW Healthcare-related errors: describe them in detail to understand them better
The realisation that a healthcare-related adverse effect was preventable is not enough to prevent similar errors. Error prevention also requires an understanding of the root causes, through in-depth analysis, preferably with everyone involved, including the patient.
Read more
--------------------------------------------------------------------------------
FREE DOWNLOAD In the December issue of Prescrire International: Stable angina and antithrombotic drugs
Addition of rivaroxaban (Xarelto°) to aspirin increases the risk of serious bleeding, but it has not been shown that the harm-benefit balance of this addition is favourable. Aspirin alone remains the first-choice antithrombotic drug in the majority of patients with coronary disease.
Read more
--------------------------------------------------------------------------------
SUBSCRIBE NOW Subscribe today for full access to top-quality content from Prescrire International
Enjoy access to subscriber-only content available on our website, including every article published in Prescrire International since 1992. Prices for a one-year subscription start at 150 euros (less for students and residents of lower-income countries).
Subscribe now
--------------------------------------------------------------------------------
Opioid overdose: an antidote to be administered promptly
Naloxone nasal spray (Nalscue°) is easy to use, and can save the lives of people who have overdosed on opioids.
Read more
--------------------------------------------------------------------------------
Drugs for hepatitis C: it's time to slash prices!
The high prices of hepatitis C drugs are an obstacle to treatment for most of the people around the world who are infected by the virus
Read more
--------------------------------------------------------------------------------
Avoid pregnancy during treatment with valproic acid or its derivatives
New measures have been taken in the European Union to prevent the exposure of fetuses to valproic acid and its derivatives.
Read more
--------------------------------------------------------------------------------
ADVANCING HEALTHCARE POLICY Drug prices, therapeutic value and access to medicines: the White Paper by 8 French civil society organisations is now available in English
Faced with significant price increases for new drugs, in North and South alike, particularly drugs for cancer, hepatitis C and rare diseases, civil society in France is taking action to defend access to best-quality care for all, and to safeguard the public healthcare system.
Read more
--------------------------------------------------------------------------------
COMING SOON Enjoy these features, and more, in our upcoming issues
Prasterone, also known as DHEA, for vulvovaginal atrophy * Severe cutaneous adverse drug reactions: sometimes avoidable * Proton pump inhibitors: increased mortality * Acute exacerbation of mild to moderate COPD * Patient organisations: in danger of conflicts of interest...
Subscribe now
Prescrire International <international@prescrire.org>